SECTION 232 PHARMACEUTICAL TARIFFS INTRODUCE A TIERED IMPORT FRAMEWORK FOR PATENTED DRUGS AND ACTIVE INGREDIENTS
The White House issued a new Section 232 proclamation establishing a tariff framework for patented pharmaceuticals and associated ingredients. The action links duty exposure to patent status, country of origin, and company participation in onshoring and pricing agreements. The structure is targeted, conditional, and designed to differentiate between patented [...]






